Objectif : Les études qui s’interrogent sur l’efficacité des interventions non médicamenteuses, dans la prise en charge de la fatigue associée au cancer, comprennent le plus souvent des sessions d’activités physiques adaptées ou des prises en charge psychologiques. Parmi elles se trouve l’hypnose, mais elle est principalement proposée en combinaison avec une autre thérapie, limitant une interprétation en termes d’efficacité. À travers cette revue de la littérature, nous voulons comprendre quelle est la place de l’hypnose pour la prise en charge de la fatigue associée au cancer. Méthode : Nous avons recherché les articles scientifiques indexés dans les bases de données Cochrane, PsycINFO, Pubmed et Web of Science. Les principaux mots clés étaient « fatigue », « cancer » et « hypnosis ». La qualité méthodologique des études a été évaluée. Résultats : Quatre-vingt-deux études ont été recensées. Après sélection, 11 études ont été retenues à la lecture. Les résultats sur l’efficacité de l’hypnose seule (non combinée à une autre thérapie) ont porté sur 6 études. Bien qu’il faille distinguer l’hypnose délivrée par autrui, de l’autohypnose par audioenregistrement, nos résultats indiquent que 4 études rapportent une efficacité significative de l’hypnose pour réduire la fatigue des patients soignés pour un cancer. Conclusion : Au niveau international, trop peu d’études évaluent l’efficacité de l’hypnose en oncologie. Ainsi, sur un symptôme spécifique comme la fatigue, les études se font encore plus rares. De plus, il est difficile d’évaluer l’efficacité d’une méthode pour laquelle l’homogénéisation de la procédure est difficile à mettre en place. Cependant, au regard de cette étude, l’hypnose présente un réel intérêt et une efficacité dans la réduction des symptômes de fatigue.
Background Acceptability and tolerance of chemotherapy on patients treated for breast cancer remain challenging. Complementary approaches such as hypnosis may have a favorable impact both at the time of announcing and during chemotherapy, due to the notorious anxiety, distress, and self‐perceived dysfunction. The objective of the study was that the patients complied with at least four self‐hypnosis sessions out of the six cycles of chemotherapy. Methods This open, prospective longitudinal study assessed feasibility of compliance to self‐hypnosis during chemotherapy in an outpatients setting. Training sessions were given by a hypnotherapist. Throughout each cycle of chemotherapy, the patient had to use self‐hypnosis to better control her anxiety or any difficulties. Nurses could offer help to the patient. Chemotherapy‐associated side effects were evaluated through the NCI‐Common Toxicity Criteria for Adverse Events v 4.03; moreover, side effects as pain, nausea, vomiting, fatigue, and anxiety were also evaluated during chemotherapy using a visual analogic scale. Health‐related quality of life, emotional distress (anxiety and depression), and cancer‐related fatigue were assessed (at inclusion, end of chemotherapy and 3 months later) using the EORTC QLQ‐C30 and QLQ‐BR23, HADS and MFI‐20 questionnaires, respectively. The number of patients screened and actually included in the study was reported, as the reasons for refusal. Results Thirty‐five patients were included with a median age of 55 years (35–78). All patients received a hypnosis training session. The overall compliance with self‐hypnosis was 68.6% (95% CI: 50.7%–83.2%), meaning that more than two thirds of patients performed at least four sessions of self‐hypnosis. According to NCI‐CTCAE, Grade 2 nausea and vomiting was observed in 45.7% and 22.9%, respectively, Grade 2 fatigue in 62.9%. Based on the HADS questionnaire, anxiety increased at the end of the chemotherapy and returned to the initial value 3 months later ( p = .97) whereas depression significantly decrease 3 months after the end of chemotherapy with respect to the inclusion ( p = .003). Role, emotional, and cognitive functioning were slightly affected throughout the treatment, in contrast to dyspnea or physical functioning. Conclusion Our study showed that self‐hypnosis was feasible on patients newly diagnosed for breast cancer receiving chemotherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.